Cargando…
Applying to dermatology residency during the COVID-19 pandemic
Autores principales: | Kearns, Donovan G., Chat, Vipawee S., Uppal, Shelley, Wu, Jashin J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the American Academy of Dermatology, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7345366/ https://www.ncbi.nlm.nih.gov/pubmed/32652192 http://dx.doi.org/10.1016/j.jaad.2020.07.011 |
Ejemplares similares
-
Reply to Letter to the Editor Regarding: “Applying to dermatology residency during the COVID-19 pandemic”
por: Kearns, Donovan G., et al.
Publicado: (2021) -
Assessing the risk of adalimumab use for hidradenitis suppurativa during the COVID-19 pandemic
por: Kearns, Donovan G., et al.
Publicado: (2020) -
Assessing the risk of dupilumab use for atopic dermatitis during the COVID-19 pandemic
por: Kearns, Donovan G., et al.
Publicado: (2020) -
Response to: “Applying to dermatology residency during the COVID-19 pandemic”
por: Alia, Erisa, et al.
Publicado: (2021) -
Third-year dermatology resident anxiety in the era of COVID-19
por: Adusumilli, Nagasai C., et al.
Publicado: (2020)